The research of the Medical Devices group is focused on the development of technologies for the understanding and diagnosis of diseases. MD works in close collaboration with the clinic to enable translational medical research towards the realisation of precision medicine. To this aim, MD works in the development of new optical instrumentation, microfluidic devices, biosensors and biomimetic systems to study and evaluate disease biomarkers, distributed in 3 different research lines:
1- Integrated nanobioengineered microfluidic systems for the isolation and characterization of tumor cells from body fluids of cancer patients and their integration in organ-on-a-chip 3D models. Lead by Lorena Diéguez.
2- Development of in vivo imaging tools based on the identification and validation of inflammatory biomarkers as indicators of cardiovascular diseases. Lead by Marina Brito.
3- Development of optical technology contributing to answer outstanding questions in the life sciences. Lead by Pieter de Beule.